Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota refers to the complex community of trillions of microorganisms, including bacteria, fungi, and viruses, residing in the human gastrointestinal tract [Nature Reviews Microbiology, 2020, 18(11): 661-673]. This ecosystem plays a critical role in host health by aiding digestion, synthesizing essential vitamins, and training the immune system to distinguish between commensal and pathogenic organisms [Science, 2012, 336(6086): 1262-1267]. Pathogenic intestinal bacteria, such as Clostridioides difficile or Salmonella, can disrupt this balance, leading to dysbiosis and various gastrointestinal or systemic diseases [Mayo Clinic, 2023]. Therapeutic interventions targeting this system aim to either eradicate specific pathogens using narrow-spectrum antibiotics or restore a healthy microbial balance through probiotics, prebiotics, and fecal microbiota transplantation [Gastroenterology, 2017, 152(8): 1829-1839]. Understanding the interactions between the host and its microbiota is essential for developing treatments for conditions ranging from inflammatory bowel disease to metabolic disorders [Cell, 2019, 178(5): 1043-1053].
Inhibition of bacterial cell wall synthesis, inhibition of protein synthesis, competitive exclusion of pathogens, modulation of host immune response, and restoration of microbial diversity through fecal microbiota transplantation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota and pathogenic intestinal bacteria.